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Introduction
Lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine, LPC) is an important lysophospholipid that is generated as a breakdown product of phosphatidylcholine by phospholipase A 2 (PLA 2 ). Present in cell membranes and oxidized lipoproteins, it plays important physiological and pathophysiological roles in both humans and animals. For instance, LPC is responsible for the delivery of fatty acids and choline to tissues (Xu, 2002) . On the other hand, elevated levels of LPC have been linked to the cardiovascular complications associated with diabetes, atherosclerosis and ischemia (Takahara et al., 1997; Shi et al., 1999; Sonoki et al., 2003) .
In the cardiovascular system, LPC adversely modifies vasoreactivity in conduit arteries.
Hence, in large artery ring preparations, LPC can impair endothelium-dependent relaxation (EDR) (Fukao et al., 1995; Froese et al., 1999; Vuong et al., 2001) , and enhance agonistinduced contractions. The latter effect includes potentiation of contractile responses induced by high-K + , UK14,304 (Suenaga et al., 2003) and angiotensin II (Galle et al., 2003; Suenaga and Kamata, 2003) . These effects of LPC may be partially explained by the results of studies in cultured endothelial and vascular smooth muscle cells, where LPC was shown to activate protein kinase C (Kohno et al., 2001) , increase intracellular Ca 2+ (Terasawa et al., 2002) and activate or inhibit MAP kinase (Bassa et al., 1999; Rikitake et al., 2000) . In addition to its role in modulating vascular contractility, it is generally accepted that LPC is the major pathological component of oxidized low density lipoprotein (LDL) in promoting atherosclerosis (Takahara et al., 1997; Sonoki et al., 2003) .
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Several lines of evidence also suggest a vaso-protective role for LPC. In rabbits, LPC produces potent endothelium-dependent vascular smooth muscle relaxation, both in vivo and in vitro (Menon and Bing, 1991; Wolf et al., 1991) . In umbilical vein endothelial cells, LPC has been shown to enhance endothelial expression of eNOS and cyclooxygenase-2 (COX-2), leading to increased synthesis of nitric oxide (NO) and prostacyclin (PGI 2 ) (Zembowicz et al., 1995a; Zembowicz et al., 1995b) . NO and PGI 2 act synergistically to block monocyte adhesion, smooth muscle cell proliferation, platelet activation, and vasoconstriction (Vane and Botting, 1995; Naseem, 2005) .
Although it has been extensively studied, the contribution of LPC in regulating vascular resistance has not been completely elucidated, as the majority of previous studies have used either large blood vessels or isolated cells. The mesenteric arterial bed (MAB) is an important effector organ regulating blood pressure, with small structural and functional changes eliciting significant alterations in peripheral resistance (Caveney et al., 1998) . The objective of the present study was to determine the vasoactive effects of LPC in the isolated perfused MAB, and to investigate the underlying mechanisms of the changes it produced.
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Methods
Animals. The investigation conforms to the guidelines of the Canadian Council on
Animal Care. Male Wistar rats were obtained from the Animal Care Center, University of British Columbia. Animals were housed under a 12 h light: 12 h dark regime, and given free access to standard rat chow (PMI Feeds, Richmond, VA), and tap water.
Isolated perfused rat mesenteric arterial bed. Male Wistar rats (300-400 g) were anesthetized with sodium pentobarbital (60mg/kg, i.p.), and the mesenteric arterial bed (MAB) was isolated as described previously (He and MacLeod, 2002) . Briefly, the abdominal cavity was opened, and the superior mesenteric artery was cannulated through an incision at its confluence with the dorsal aorta. The whole MAB was then separated by cutting close to the intestinal border. The MAB was flushed with heparinized warm Krebsbicarbonate buffer with the following composition: 113 mM NaCl, 4.7 mM KCl, 11.5 mM glucose, 1.2 mM MgSO 4 , 2.5 mM CaCl 2 , 1.2 mM KH 2 PO 4 , and 25.0 mM NaHCO 3 . The pH of the buffer following saturation with a 95% O 2 -5% CO 2 gas mixture was 7.4.
Subsequent to flushing, the MAB was transferred into a jacketed organ chamber, and perfused through the cannula with Krebs buffer maintained at 37°C, and gassed with 95% O 2 -5% CO 2 . Perfusion rate was kept constant at 3 ml/min using a peristaltic pump (Buchler Instruments, Buchler Fort Lee, N.J.). The perfusate flowed out through the cut ends of the mesenteric arterial bed. Vascular responses were detected as changes in perfusion pressure, and this was continuously measured and recorded using a pressure transducer (PD23ID, Enzyme-immunoassay (EIA) of TxB 2 . The collected perfusates were extracted using Solid Phase Extraction C-18 Cartridges (Cayman Chemical, Michigan, USA) following cartridge activation by 5 ml of methanol and 5 ml of ultra-pure water. A 0.5 ml aliquot of each sample was acidified to ~ pH 4.0, and loaded onto the cartridge. The cartridge was washed with 5 ml of ultra-pure water, followed by 5 ml hexane. The TxB 2 fraction was eluted with 5 ml ethyl acetate containing 1% methanol. The eluate was dried under a stream of nitrogen, and reconstituted with 0.5 ml EIA buffer. All data are presented as mean ± S.E.M. Data were analyzed for significant differences using NCSS. Student's unpaired t test was used for comparisons between two means.
One-way ANOVA followed by Newman-Keul's test was used for comparison of more than two means. Two-way ANOVA, using the general linear model approach (repeated 
KCL-induced contractile responses following LPC. Pressor responses of the MAB to
bolus injections of KCl (50-800 µmol) were not significantly altered, either during perfusion with 10 µM LPC, or after LPC washout ( Fig. 2A) . In untreated control tissues, KCl-DRCs remained constant over time (Fig. 2B ).
Effects of LPC on PE-induced contractile responses.
Bolus injection of PE (0.9-300 nmol) produced a concentration-dependent increase in perfusion pressure that did not significantly change over time (Fig. 3A) . The response to PE was unaffected by prior perfusion with LPC for either 40 (Fig. 3B ) or 150 (data not shown) min. Interestingly, following washout of LPC for 1 hour, the PE response was markedly enhanced (Fig. 3B ).
The maximum response to PE increased to 199±24% of control (P<0.001) following LPC washout, while the PE pD 2 value increased from 7.50±0.04 to 8.13±0.15 (P<0.001).
Further increasing the dose of PE above 90 nmol resulted in a decline in the contractile response.
This article has not been copyedited and formatted. The final version may differ from this version. Involvement of NO and TxA 2 in mediating the direct effects of LPC perfusion. Prior to LPC perfusion, Ach (0.1-0.3 µmol) produced a maximum relaxation of 93±5% of the response to PE (Fig. 4, left panel) . The Ach response remained unchanged over time (Fig.   4 , right panel). LPC perfusion almost completely abrogated the response to Ach, reducing the maximum relaxation to 7±4% (Fig. 4, left (Fig. 6 ). LPC perfusion for 40 min had no effect on basal levels of TxB 2 but suppressed its enhancement by PE (Fig. 6 ), suggesting that LPC prevents the ability of PE to increase TxA 2 production.
Involvement of NO and TxA 2 in mediating the indirect effects (after washout) of LPC. Washout of LPC induced partial recovery of the Ach response (Fig. 4) . Despite this fractional recovery, contractile responses to PE were augmented (Fig. 3B) , suggesting that 
Discussion
To our knowledge, the present study is the first to investigate the effects of LPC on the reactivity of a perfused resistance artery bed. As reported previously in conduit blood vessels, LPC perfusion of MAB caused impairment in Ach-induced maximum relaxation.
The novel finding in the present study was the potentiation of PE-induced contractile responses following washout of LPC, an effect likely related to increased production of Unexpectedly, the response to PE was dramatically potentiated only following removal of LPC. A time-dependent mechanism can be ruled out, as prolonged perfusion with LPC (150 min) did not produce any potentiation of PE responses. The enhancement of the PE response could be blocked by both indomethacin and SQ-29548, suggesting an important contribution of vasoconstrictor prostanoids, which was confirmed by the finding of potentiation of PE-induced TxA 2 production. At present, the mechanism for this rebound production of excessive TxA 2 is not known, nor is it clear whether this effect is global, or localized to the MAB. The contribution of time in producing the potentiated contractile responses and TxA 2 production in response to PE can be ruled out, as these were stable over time in the absence of LPC. These effects were unlikely to be due solely to continued endothelial impairment, as Ach-induced relaxation had partially recovered. Furthermore, the enhancement of PE responses produced by mechanical removal of the endothelium could not be abolished by pretreatment with SQ-29548 (data not shown).
As a potent inducer of platelet aggregation, vasoconstriction and bronchoconstriction, TxA 2 has been implicated in vascular pathogenesis (Dogne et al., 2004) . Although the major source of TxA 2 is platelets, this vasoconstrictor can also be produced within the vascular walls, by both endothelial (Ally and Horrobin, 1980) and smooth muscle cells (Shiokoshi et al., 2002 production in the vasculature has not previously been reported. However, our observation that LPC abrogated the increase in TxA 2 production produced by PE in the MAB is consistent with a previous study in platelets, in which an inhibitory effect of LPC on agonist-induced TxA 2 production was observed (Yuan et al., 1996) . Although we are not aware of any studies showing potentiation of TxA 2 production by LPC, an interaction between these two agents has previously been suggested. For instance, LPC was found to enhance the ability of TxA 2 to increase vascular smooth muscle cell proliferation (Koba et al., 2000) . Taken together, these findings strongly suggest that LPC is able to alter the biosynthesis of TxA 2 , as well as its downstream signaling. Details of the mechanism of these modulatory effects need to be further investigated. Irrespective of the mechanism(s), the increased release of TxA 2 could be a major contributor towards hypertensive (Seeger et al., 1989) , thrombotic and ischemic diseases (Ally and Horrobin, 1980; Muller, 1991) .
It is tempting to speculate that conditions that evoke an increase in LPC levels initially trigger compensatory mechanisms to neutralize its injurious effects. Thus, the suppression of PE-induced TxA 2 production could compensate for the endothelium dysfunction. Wu and coworkers have also suggested that LPC is a double-faced molecule, which can produce both vasoprotective and proatherogenic mechanisms (Zembowicz et al., 1995a; Zembowicz et al., 1995b ). An additional caveat is the suggestion that residual effects of This article has not been copyedited and formatted. The final version may differ from this version. LPC after washout could arise from its metabolism to lysophosphatidic acid (Tokumura, 2004) . Given this complex biology, investigation of the in vivo temporal effects of LPC under normal and pathological conditions would be beneficial.
In conclusion, our results for the first time demonstrate effects of LPC in the rat resistance arterial bed, even following washout. These included potentiated PE responses, and enhanced TxA 2 production. Thus, when evaluating the effects of LPC in the vasculature, both its immediate and residual effects need to be considered. Although unclear, the mechanism for this residual effect, especially the relationship between LPC and LPA, is currently being evaluated.
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